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Abstract.  The plasma protein fibronectin is an impor- 
tant opsonin in wound repair and host defense. To bet- 
ter understand the process of fibronectin-mediated 
phagocytosis, we have transfectod K562 cells, which 
endogenously express 0~5fll, with a,f13. In these trans- 
fectants, antibodies to t~fl3 block phagocytosis of 
fibronectin-opsonized beads completely, even though 
half the ingestion occurs through endogenous 0t5/3~ 
receptors,  c~5/31-mediated adhesion to fibronectin- 
coated surfaces is unaffected by c~j33 ligation.  Neither 
av/$5 nor  O/M/~2 ligation affects O~5/~1 phagocytic function 
in transfectants expressing these receptors.  Pharmaco- 
logic data suggest that o~v/~3 ligation suppresses the 
phagocytic competence of high affinity ot5/$1  receptors 
through a  signal transduction pathway,  perhaps involv- 
ing protein kinase C. In addition to its significance for 
phagocytosis, otv/33 regulation of o~5/31 function may be 
significant for its roles in cell migration,  metastasis, 
and angiogenesis. 
M  ACROPHAGE interaction  with fibronectin  (Fn) 1 is 
recognized as an important aspect of host defense 
and  wound  repair.  Fibronectin  opsonlzation  is 
necessary for macrophage recognition  and phagocytosis of 
particulate  debris  released  from  tissues  after  bum  and 
trauma (23, 41, 53, 58), resolution of bacteremia during sep- 
sis (48, 53), and clearance of fibrin during disseminated in- 
travascular coagulation  (9, 11, 60). In addition,  macrophage 
adhesion  to fibronectin-coated  surfaces affects a variety of 
macrophage functions including chemotaxis  (25, 50), differ- 
entiation  (8),  secretion (7, 45),  and phagocytosis via im- 
munologic receptors (12, 52, 66). Nonetheless, the molecu- 
lax nature of the interactions  leading to these critical macro- 
phage functions is unknown. 
Studies  which  have  examined  fibronectin  receptors on 
macrophages in detail have demonstrated an unexpectedly 
large number of integrin and non-integrin fibronectin-binding 
proteins (10, 13, 16, 17, 29, 42, 59, 63). Four integrin recep- 
tors with fibronectin binding capability  have been identified 
on mononuclear phagocytes.  Fibronectin binding to VLA-5 
(ot5/~1), the vitronectin  receptor (otJ~3) and the Leukocyte 
Response Integrin  (LRI)  appears  dependent on the  RGD 
adhesion sequence (13, 16, 29); (VLA-4 (~,)  binds fibro- 
nectin independent  of this sequence (28). Additional macro- 
phage integrins  ~J~5, VLA-3  (ot3/~,), and OtM/~2, may also 
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bind fibronectin  (1%42,59,63). To add to the complexity of 
fibronectin binding by macrophages,  several of these recep- 
tors can recognize alternative, potentially competing ligands. 
Moreover, a~/31 and perhaps other of these integrins  can as- 
sume two affinity states for fibronectin  (26).  The existence 
of these distinct  but related receptors for the same ligand 
suggest  that  they may have different  roles in macrophage 
function.  The purpose of the present work was to begin to 
determine how these various receptors contributed to adhe- 
sion and phagocytosis~ Because of the complexity of fibro- 
nectin receptor expression  on macrophages,  we have exam- 
ined fibronectin-mediated adhesion and phagocytosis in K562 
cells, which express only tx5/31. We have found this integrin 
capable of both functions. When K562 were transfected with 
txJ33, ligation of c~v/3a with antibody or vitronectin  inhibited 
both txJ33- and cq/3~-mediated phagocytosis but had no effect 
on  t~5/3t-mediated adhesion.  Pharmacologic  data  support 
the hypothesis  that the effect of av/~3 ligation on tXs/3t func- 
tion requires a signal transduction  pathway involving a ser- 
ine/threonine  kinase. These data show that there is crosstalk 
among integrin receptors. This previously unrecognized  role 
for the tXvJ33 integrin  in differential  regulation  of functions 
of c~5/31 may be important not only in macrophage  biology, 
but also in the function of Oev/33  in cell migration,  angiogen- 
esis,  and metastasis (21, 42, 61). 
Materials and Methods 
Cells 
The  human erythroleukemia cell line K562  was maintained in  Iscove's 
Modified Dulbecco's Medium (GIBCO BRL, Gaithersburg, MD), contain- 
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Chem.  Co.,  St.  Louis,  MO)  and propagated in a  37°C,  5%  CO2,  hu- 
midified incubator. Human monocytes were collected from healthy, normal 
volunteers by leukopheresis and purified to >95 % by elutriation as de- 
scribed (69). Monocytes were cultured for 5 d in RPMI with 10% FBS on 
bacteriologic plastic and treated with 50 ng/ml GM-CSF for the last 16 h, 
as described (22). For experiments, monocytes were washed with PBS and 
removed  from the plate after incubation with PBS containing 5.0 mM EDTA 
for 2 h at 40C. 
cDNA Clones and Cell Transfection 
The human/35 integrin subunit eDNA was the gift of Dr. Sarah Bodary, 
Genentech, Inc. (San Francisco, CA) (46). Human integrin ev eDNA (44) 
was a gift of Dr. Joseph C.  Loftus, Scripps Research Institute (La Jolla, 
CA). Human/~3 integrin eDNA was the gift of Dr. Jeffrey Smith (Scripps 
Research Institute). For transfection, the ~5 and/~3 eDNA were cloned into 
the stable expression vector pRc/RSV (Invitrogen, San Diego, CA) (/~5) or 
a derivative of pRc/RSV with the multicloning sites HindIII and XbaI in re- 
verse orientation, (/33) (43).  The ev eDNA was in pCDM8 (invitrogen). 
K562 cells were cotransfected with either otv and/~3 or ¢~ and B5 by elec- 
troporation at 200 V, 600 uF using a Gene Pulser (Biorad Labs., Richmond, 
CA). Transfected cells were selected in media containing 1,200 #g/ml G418 
(Genticin, Gibeo), and populations of transfectants expressing the trans- 
fected integrin were obtained by fluorescence cell sorting. K562 were stably 
transfected with c~M/~2 were as described (Graham, I. L., and E. J. Brown, 
manuscript submitted for publication). Control K562 were transfected with 
pRc/RSV vector alone. 
Protein Purifications 
Fibronectin was provided by Dr. John E. Keplan, Albany Medical College 
(Albany, NY), and was prepared as described by gelatin affinity chromatog- 
raphy (11). Vitronectin was prepared as described (68) by denaturation and 
adsorption on beparin.  Casein was  purchased in  solution from Pierce 
(Rockford, IL). Purity of all protein reagents was determined to be greater 
than 99%  by SDS-PAGE. 
Antibodies 
Polyclonal antibody against human C~vB3 and ¢XvBs  integrins were purchased 
from Gibco Laboratories. The avB5-specific  monoclonal antibody (mAb) 
P1F6 (63)  was the gift of Dr.  Dean Sheppard (University of California at 
San Francisco).  The C~v/33-reactive mAb LM609  (15)  was a  gift of Dr. 
David Cberesh (Scripps). The t31-reactive mAb P5D2 (14) was purchased 
from the Developmental Studies Hybridoma Bank (Iowa City, IA). The 
rnAb BIIG2 and AIIB2, reactive with human integrin subunits ¢x5 and B1, 
respectively (33, 64), were the kind gift of Dr. Caroline Damsky (Univer- 
sity of California at San Francisco). The human integrin c~5-reactive mAb 
16 (20) was the gift of Dr. Kenneth Yamada,  NIDH/NIH (Rockville, MD). 
rnAb IB4 (67) was the gift of Dr. Sam Wright, Rockefeller University (New 
York, NY). The Bt integrin-activating antibodies AIA5 (34) and 8A2 (39) 
were generously provided by Dr. Martin Hemler, Dana-Farber Cancer In- 
stitute (Boston, MA), and Drs. Nick Kovach and John Harlan, University 
of Washington (Seattle, WA); respectively. The HLA reactive mAb W6/32 
(6) was purchased from the American Type Culture Collection (Rockville, 
MD).  mAbs 7(32 specific for human integrin B3,  and  3F12  and  1C12 
specific for human integrin c~v were made as described (31).  Fluorescein- 
labeled antibodies directed against rat or mouse IgG were purchased from 
Sigma Chem. Co. All antibodies were used as purified IgG. 
FACS  Analysis of  Receptor Expression 
Receptor expression on  macrophages and  K562  cells was  analyzed by 
fluorescent flow cytometry as described (13, 43). 
Flow Cytometric Particulate  Phagocytosis  Assay 
Fluoresceinated ligand (40)  was covalenfly coupled to 3.0 micron amino 
polybeads (Polysciences, Warrington, PA) via an 8 carbon bridge according 
to manufacturer's instructions, and ligand-opsonized beads were presented 
to cells in suspension. Bead ingestion was determined by a modification of 
previously described assays (3,  30).  Briefly,  after washing in  HBSS-- 
(GIBCO),  cells were resuspended at 3  x  106/ml in HBSS with 1.0 mM 
each of Mg  ++, Mn  ++, and Ca  ++ with 0.5 % Human Serum Albumin (HSA) 
(Assay Buffer) containing inhibitors at given concentrations with vehicle con- 
trois or purified polyclonal or monoclonal antibodies at 5.0 #g/ml with 
preimmune sera or isotype matched controls, respectively. Ligand-coated 
beads were vortexed to resuspend, sonicated for 10 s to disperse aggregates, 
counted on a hemocytometer and added to cells at a target: cell ratio of 
1,000:1. Samples were incubated for 2 h with gentle rocking at 370C unless 
otherwise stated. Cell-associated fluorescence was determined using a flow 
cytometer (EPICS, Coulter Diagnostics, Miami, FL) set to measure for- 
ward and side scatter as well as fluorescence, with and without the addition 
of 0.05 % trypan blue, which was sufficient to quench fluorescence of ex- 
tracellular beads. Phagocytosis was quantitated by determining the mean 
fluorescence of 10,000 cells in the presence of trypan blue, normalized to 
the fluorescence of a single bead, and expressed as a Phagocytic Index (PI), 
the number of beads internalized per 100 cells PI (31). The assay was vali- 
dated by comparing data obtained by flow cytometry with direct observation 
by fluorescence microscopy. As expected, pretreatment of phagocytic cells 
with 5/~g/ml cytochalasin D completely abolished cell-associated fluores- 
cence after trypan blue in this assay, confirming that trypan blue-resistant 
fluorescent beads were ingested. 
Adherent Cell Bead Attachment Assay 
Multiwell Lab-Tek  Chamber Slides (Thomas Scientific, Swedesboro, NJ) 
were coated with either fibronectin, vitronectin, or casein at 50 #g/ml in 
PBS or mAb at 5/~g/rnl in PBS overnight at 4"C. Wells were washed twice 
with PBS and postcoated with 1.0% casein in PBS for 30 min at 37°C. Cells 
were added to the wells at 2  x  106/ml in HBSS containing 1.0 mM Ca  ++ 
and Mg  ++ and adhered for 2  h  at 37°C resulting in sparsely distributed 
cells. Wells were rinsed and ligand-opsonized beads prepared exactly as 
above were added to the cells in Assay Buffer at a 500:1  target to cell ratio. 
After an additional 2  h at 370C,  unbound beads were removed by three 
washes with PBS, the chambers removed, and slides wet mounted. Beads 
associated with cells were counted manually by light microscopy and the 
number of beads attached per 100 cells was determined (Attachment Index, 
AI) as previously described (31). 
Cell Adhesion 
96-well rnicrotiter plates (Dynatech, Chantilly, VA) were coated with iigand 
as described above. Cells were washed as above, labeled with Calcein AM 
fluorescent dye (Molecular Probes, Eugene, OR) according to manufac- 
turer's instructions and suspended in Assay Buffer. Cells and inhibitors were 
added to wells in 200 ttl at 106/ml and incubated for 1.5 h at 37"C. Plates 
were rinsed twice gently with PBS and adhesion measured in a fluorescence 
plate reader (Cytofluor 2300,  Millipore, Marlborough,  MA).  Adhesion 
data is presented in arbitrary fluorescence units with internal controls. 
Reagents 
H7,  HA-1004,  calphostin C,  genestein, herbimycin, PMA,  and phorbol 
dibutyrate (PDBu)  were all purchased from LC  Laboratories (Woburn, 
MA). All other reagents were purchased from Fisher America (Waukesha, 
WI). 
Data Presentation 
Data are presented as either the mean +  SEM or as a representative study 
from at least three yielding equivalent results. Significance was determined 
by analysis of variance followed by Duncan's comparison testing. A mini- 
mum confidence interval of 95%  was used in all analyses. 
Results 
Fibronectin Bead Phagocytosis by 
Human Macrophages 
To investigate  which  macrophage  integrin  receptors  were 
responsible  for  attachment  and  ingestion  of  fibronectin- 
opsinized particles, we tested the effect of mAb against vari- 
ous macrophage integrins (or HLA class I as a control) on 
Fn  bead  binding  to  adherent  cultured  human  monocytes 
(Fig.  1). In vitro culture of monocytes induces expression of 
o~vB5 and c~vB3 (Fig.  2 A and  [22]);  c~5B1 is present on pe- 
ripheral blood monocytes and is maintained during in vitro 
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Cultured human macrophages adherent to plastic were incubated 
with fibronectin-coated beads and various mAb in the presence or 
absence of mAb 7G2 (anti-~3). Fibronectin bead attachment was 
assessed as described in Materials and Methods. More than 90% 
of attached beads were ingested (not shown). Data are expressed 
as the percent of casein-coated bead binding under identical condi- 
tions. Shown is a representative of three equivalent studies. Mono- 
clonal antibody reactivities are shown in parentheses. 
culture.  Attachment  of fibronectin-coated beads  was  de- 
creased almost equivalently by mAb 7G2 (anti-~3), mAb 16 
(anti-ors),  and P5D2 (anti-/3~). Neither P1F6 (anti-av/35) nor 
W6/32 (anti-HLA class I) had any effect on fibronectin bead 
phagocytosis. Surprisingly, the effects of the inhibitory mAb 
were not additive, since the combination of anti-~3 with ei- 
ther anti-~5  or anti-~  resulted in no additional inhibition. 
These data suggested that f13 integrins and o~5~ did not act 
independently in fibronectin bead binding by macrophages. 
This suggested that binding of fibronectin to one integrin 
might affect the function of  other potential fibronectin recep- 
tors. However, the complexity of expression of fibronectin 
receptors in macrophages precluded a more detailed analysis 
of this possibility. 
Fibronectin Bead Phagocytosis by Transfected K562 
To pursue  the  question  of interaction  between  o~/33 and 
c~sB~,  a  cell with a  simpler pattern of integrin expression 
than macrophages was desirable. Thus, the erythroleukemia 
cell  line  K562  was  stably  transfected  with  ol~#5 or  ct~/33 
(Fig. 2 A). K562 were chosen because they can be phagocytic 
(Graham, I. L., and E. Brown, unpublished) and because, 
unlike macrophages, they express a very limited number of 
integrins,  predominantly ot5/31. K562 expressed no detect- 
able  ct~  integrins  in  the  absence of transfection (data  not 
shown), or when transfected with vector alone (Fig. 2 A). 
Transfection  with  or,#3 and  u~5  led  to  approximately 
equivalent levels of antigenic and  functional receptors, as 
demonstrated by fluorescence with  receptor-specific anti- 
body (Fig. 2 A) and by ingestion of vitronectin beads (Fig. 
2 B). Further, fluorescence of ct, expression in transfected 
K562 cells expressing ot,.~3 or otv~5 was equivalent as as- 
sessed by flow cytometry using an oL,-specific monoclonal 
antibody IC12 (data not shown). Transfection did not affect 
expression of or5 (data not shown) or ~  (Fig. 2 A). 
a,/33  and  oev/35 transfectants  and  the  vector  controls 
phagocytosed fibronectin beads  (Fig.  2  B).  Ingestion  of 
fibronectin-opsonized beads was greater in cells transfected 
Figure 2.  Expression  and  function of c~v-integrin receptors  in 
transfected K562 and human macrophages. K562 cells were trans- 
fected with a,/~3 or c~v~5 integrins,  and human monocytes were 
cultured  to  induce  expression  of c~v  integrins  as  described  in 
Materials and Methods. (A) FACS analysis of c~, integrin receptor 
expression. (B) The ability of transfected K562 integrins to bind 
and internalize opsonized particles was determined using the flow 
cytometric phagocytosis assay described in Materials and Methods. 
Data are the summary of three independent experiments. Monoclo- 
nal antibody reactivities are shown in parentheses. 
with (:gv~3  than those transfected with av~5 or vector, sug- 
gesting that, as in macrophages, ot,~3 can contribute to the 
ingestion of fibronectin beads in transfected K562.  Treat- 
ment with phorbol esters (1-100 ng/ml) for up to 2 h had no 
effect  on the phagocytosis of  flbronectin or vitronectin beads. 
The effects of anti-integrin antibodies on fibronectin bead 
phagocytosis by  vector-  and  av~3-transfected  K562  were 
determined  (Fig.  3).  Phagocytosis  by  vector-transfected 
cells  was  inhibited  by  mAb's  BIIG2  (anti-cts)  or  AIIB2 
(anti-~L) to the same extent as by chelation of all divalent 
cations with EDTA.  This very low level of ingestion was 
equivalent to the nonspecific ingestion of casein opsonized 
beads  (not shown),  mAb  16  (anti-ors)  and  P5D2  (anti-/31) 
also inhibited fibronectin bead phagocytosis (not shown). In- 
hibition of t~5/3~ function with the same  mAb in the t~v~3 
transfectants resulted in an ,'~50% decrease in phagocytosis. 
Monoclonal and polyclonal antibodies at 5.0 #g/ml against 
ot,fl3 had  no effect on phagocytosis by control K562,  but 
completely abolished phagocytosis in the a,fl3 transfectants 
at the same concentration, mAb 7G2 (anti-fl3) and LM609 
(anti-av~3)  inhibited equivalently at 5.0  #g/ml.  This effect 
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Figure 3. Antibody inhibition of fibronectin bead phagocytosis by 
transfected K562 cells.  K562 cells transfected with vector (pRc/ 
RSV) or  with  ~x~fl3 were  presented  with  fibronectin-opsonized 
beads in the fluid phase, with and without polyclonal antibodies to 
¢x~B3 or various monoclonal  antibodies against integrin  subunits. 
Antibodies were included as purified IgG at 5.0 #g/ml. Phagocyto- 
sis was assessed as in Fig. 2. Bars labeled EDTA were performed 
in a buffer identical to standard assay buffer, except that EDTA (5 
mM) was included in place of divalent cations. Nonimmune rabbit 
IgG, a control for the polyclonal anti-a,  B3, had no effect on inges- 
tion  (not  shown). Data,  expressed  as the phagocytic  index  (PI, 
number of beads  ingested/100 cells),  are the  summary of eight 
studies. For all studies, the PI for casein-opsonized beads averaged 
less  than  12  (not  shown).  Monoclonal  antibody  reactivities  are 
shown in parentheses. 
required recognition of specific ed~3 epitopes, since fibro- 
nectin bead phagocytosis was not inhibited by 3F12, an im- 
munoprecipitating  antibody  against  ~v  (31)  which  has  no 
known inhibitory properties although it has greater affinity 
for t~,/3a than LM609 or 7G2 as assessed by flow cytometry. 
Thus,  ligation of a,~a with antibody resulted in inhibition 
of the  phagocytic capability of txS/~l as  well as  ad~3;  this 
conclusion can explain the non-additive inhibitory effects of 
the mAbs on fibronectin bead attachment to macrophages 
(Fig.  1). 
Anti-~#~3 Fails to Inhibit Adhesion ofK562 
Transfectants to Fibronectin 
Since mAb against ~d33 inhibited phagocytosis by txs/3L, we 
evaluated  the  effect of these  antibodies  on  cB/~rmediated 
adhesion  to  fibronectin-coated  substrate  (Fig.  4).  Vector 
transfectants  showed  fibronectin  dose-dependent  adhesion 
which  was inhibited  by PSD2  (anti-/~)  at all coating con- 
centrations of fibronectin (Fig. 4  A).  As expected,  neither 
polyclonal  antibody  to  ad33 or  mAbs  7G2,  3F12,  or 
LM609  had  any  effect  on  the  adhesion  of  the  vector- 
transfected cells (Fig. 4 A and data not shown).  In contrast 
to  fibronectin  bead  phagocytosis,  adhesion  of  the  ad33 
transfectants to the fibronectin substrate was almost entirely 
inhibited by the anti-/3~ mAb (Fig. 4 B).  In the absence of 
anti-/3~, neither polyclonal antibody against ad3~ nor any of 
the anti-c~d3~ mAb significantly affected adhesion by these 
cells. This was true at multiple coating densities of fibronec- 
tin,  suggesting  that  the  difference  between  adhesion  and 
phagocytosis could not be attributed to differences in ligand 
density between coated substrate and opsonized bead.  The 
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Figure 4. Adhesion of transfected K562 cells to fibronectin. K562 
cells transfected with vector (A) or with ad33 (B) were adhered to 
substrate  coated with varied concentrations  of fibronectin in the 
presence and absence of PSD2 (anti-B0 or polyclonal antibody to 
uvfl3. Binding was performed in assay buffer or in buffer contain- 
ing 5  mM EDTA rather  than  divalent  cations  (EDTA). In both 
panels,  the  filled circle  represents  binding  to casein-coated  (50 
/~g/ml) wells. Data are expressed in arbitrary fluorescence units. 
Shown is  a  representative  of three  studies  yielding  comparable 
results. 
limited fibronectin adhesion of the t~v/33 transfectants in the 
presence of anti-/3~ was inhibited to baseline by the addition 
of  polyclonal  antibody  against  otd33, demonstrating  that 
these are the only functional fibronectin adhesive receptors 
on these cells. 
Adhesion to a,B~  Ligands Blocks Fibronectin 
Bead Binding 
One explanation for the effect of the anti-t~d33 on ot5~1 func- 
tion  is  that  these  antibodies  somehow  sterically  interfere 
with ol5/31 ligand binding.  The failure of anti-otv~3 to inhibit 
cts/~rmediated adhesion (Fig. 4) is evidence against this hy- 
pothesis.  To further explore this possibility,  we  examined 
fibronectin bead binding on cells adherent to various mono- 
clonal antibodies or protein substratcs (Fig. 5). Adhesion to 
anti-c~5 (BIIG2) or to anti-E1 (AIIB2) decreased the  fibro- 
nectin bead binding of controls and txvB3 transfectants 37 % 
compared to adhesion to casein or the control mAb W6/32 
(anti-HLA class I). Adhesion to fibronectin also had mini- 
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Figure 5. Fibronectin bead binding by transfected K562 ceils adher- 
ent to antibody  or ligand.  K562 cells transfected with vector or 
tx~B3 were adhered to wells coated with mAb, integrin ligands, or 
casein. Fibronectin-opsonized  beads were presented to these ceils 
and  bead attachment  determined  as described  in  Materials  and 
Methods. Data are presented as the Attachment Index (AI) and are 
the summary of three independent studies. AI of casein-opsonized 
beads in parallel samples averaged less than 25 (not shown), mAb 
reactivities are shown in parentheses. 
nud effect on fibronectin bead binding.  This minimal effect 
is consistent with previous data (32).  Residual fibronectin 
bead binding in cells adherent to fibronectin was completely 
(controls) or partially (transfectants) inhibited by antibody to 
or5 or B! in solution (data not shown), and is consistent with 
redistribution of a small proportion of fibronectin receptors 
from the apical to the basal adherent surface (47).  In con- 
trast,  adhesion  to  vitronectin  or to  the  anti-B3  mAb 7G2 
blocked fibronectin bead binding to the otvB3 transfectants 
completely despite the observation that  significantly more 
cells  were  adherent  to  fibronectin  or  anti-otsB!  antibody- 
coated substrates  (data  not  shown).  Thus variation in  the 
number of cells adherent to each substrate cannot account 
for  the  observed differences  in  fibronectin  bead  binding. 
Adhesion  to 7G2 or vitronectin had no effect on otsB! ex- 
pression or distribution on the transfected cells, as judged by 
fluorescence microscopy (not shown). These data show that 
ligation of a,B3  on the basal adherent cell surface inhibits 
the binding and phagocytosis of fibronectin beads by o~sBt 
on the apical cell surface. In contrast,  ligation of txsB~ did 
not block fibronectin bead binding by ot~B3. Cell adhesion 
to  anti-Bt  (Fig.  6)  or  to  fibronectin  (not  shown)  did  not 
affect vitronectin bead binding by the transfectants. 
Ligation of .j~3 but Not .~  or otuB2 Inhibits 
~sBrmediated Phagocytosis 
To determine whether integrins other than txvB3 could affect 
t~sB,  phagocytosis,  we  examined  K562  transfected  with 
aMB2 and with -vB5 (Fig. 6). In K562 cells transfected with 
aMB2, ligation of otMB2 with mAb IB4 did not affect fibro- 
nectin phagocytosis, whereas anti-B~ mAb AIIB2 inhibited 
completely (Fig. 6 A). These cells expressed otuB2 at levels 
greater  than  activated  neutrophils,  as  assessed  by  flow 
cytometry using antibody 1B4 (data not shown).  Complete 
inhibition by AIIB2 suggests that ot~2 does not contribute 
to  fibronectin  bead  binding,  and  these  transfectants  are 
Figure 6.  Opsonized bead attachment  and phagocytosis by K562 
cells  transfected  with  ~XvB5 or  O/M~2. (a)  K562 transfected  with 
~XM/$2 were presented  with fibronectin beads  in the presence  and 
absence of monoclonal antibody specific for tXsB~ (AIIB2) or CtMB2 
fIB4) and phagocytosis assessed by flow cytometry as in Fig. 2. An- 
tibodies were included as purified IgG at 5.0/~g/ml. (B) Attachment 
of fibronectin-, casein-,  and vitronectin-opsonized  beads was as- 
sessed in K562 transfected  with c~vlB3 or txvB5 adherent  to mAb 
specific for K562 integrins or HLA. Bead attachment to adherent 
cells was determined as in Fig. 5. Data in each panel are presented 
as the summary of  three independent experiments, mAb reactivities 
are shown in parentheses. 
equivalent to the control, vector-transfected K562 with re- 
spect  to  fibronectin  bead  phagocytosis.  Additionally,  in 
studies  similar to that  shown in  Fig.  5,  adhesion of otMB2 
transfected K562  to  substrate  coated with IB4 or  C3B,  a 
tXMB2 ligand, had no effect on fibronectin bead binding (data 
not shown). 
In the  oLvBs transfectants,  adhesion  to mAb PIF6  (anti- 
txvBs) (Fig.  6  B)  or  vitronectin  (data  not  shown)  had  no 
effect on fibronectin bead phagocytosis. Nonetheless, it did 
eliminate vitronectin bead binding. As with the ctMB2 trans- 
fectants, fibronectin bead binding was completely abolished 
by addition  of mAb against otsBl in  solution  (not  shown). 
Thus,  ligation of integrins  other than c~vB3 does not affect 
fibronectin bead binding by otsB1. 
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phagocytosis. Phagocytosis of fibronectin-opsonized beads was as- 
sessed in K562 cells transfected with vector or av/33 in the pres- 
ence or absence of purified mAb anti-c~vj33 (LM609)  at 5.0 #g/ml 
and  various  inhibitors  of signaling pathways; H7 (50 nM),  cal- 
phostin C  (100 nM),  Genestein (50 #g/ml),  and Herbimycin (10 
/zg/ml). Data, expressed as the phagocytic index, are the summary 
of three studies. 
av[33-mediated Inhibition of ~d31 Is Blocked by H7 
Ligation of C¢v/33 might affect c~5/3~ phagocytosis through a 
second messenger signaling pathway. To investigate this pos- 
sibility, we determined the effects of various pharmocologic 
inhibitors on the ability of anti-/33 to block fibronectin bead 
phagocytosis (Fig.  7).  While  1-(5-Isoquinolinesulfonyl)-2- 
methylpiperazine dihydrochloride  (H7),  a  serine/threonine 
kinase inhibitor, had no effect on phagocytosis by either con- 
trols or cry/33 transfectants,  it completely reversed the inhi- 
bition  of phagocytosis  resulting  from  LM609  ligation  of 
txv~3. H7 reversal of inhibition was dose dependent, with an 
ICso of 5.0 nM (data not shown).  HA-1004,  which inhibits 
cAMP-dependent  protein kinase  similarly to  H7,  but  is  a 
poor inhibitor of protein kinase C  (35), had no effect on the 
LM609 effect at concentrations up to 1/zM.  Calphostin C, 
a more selective inhibitor of protein kinase C (37) also par- 
tially  reversed  the  LM609  inhibition  of fibronectin  bead 
phagocytosis,  with an ICs0 12.5  nM.  The tyrosine kinase 
inhibitors genestein and herbirnycin had no effect on fibro- 
nectin bead phagocytosis, whether or not LM609 was in- 
cluded in the assay. These data support the hypothesis that 
a~/33  ligation  affects  a5/3~ phagocytic  function  through  a 
signal transduction pathway, possibly involving protein ki- 
nase C. 
Phagocytosis by ~j/31 in K652 Cells Requires Mn  ++ or 
Activating mAb 
There was very little Fn-mediated phagocytosis in K562 in 
the absence of Mn  ÷+, whether or not they had been trans- 
fected with a~/33 (Fig. 8). Incubation of K562 with "activat- 
ing" mAb which recognized the integrin 131 chain (4, 5, 54) 
induced efficient Fn-mediated phagocytosis in both control 
and C~v/33-expressing K562 in the  absence of Mn  ++ (Fig.  8 
A).  Addition  of 750  nM  (300  /~g/ml)  soluble  fibronectin 
completely inhibited  phagocytosis of fibronectin beads  in 
Figure 8. Effect of soluble fibronectin and of activating antibodies 
on  fibronectin  bead  phagocytosis.  Phagocytosis  of fibronectin- 
opsonized beads was assessed in K562 transfected with vector or 
txv/33 in assay buffer containing Ca  ++ and Mg  ++ alone (-), with the 
addition of Mn  ÷÷ (Mn++), or in the presence of mAb A1A5 or 
8A2 in assay buffer without Mn  ++ (control). The effects of 750 nM 
soluble fibronectin (+  soluble FN) (upper panel) and mAb 7G2 
(anti-/3~) with  (+  7G2 & H7)  and  without  25  nM H7 (+  7G2) 
(lower  panel) on fibronectin phagocytosis was determined in c~v/33- 
expressing K562. All antibodies were used as purified IgG at 5.0 
/zg/ml. Data presented as the Phagocytic Index, are representatives 
of  five studies yielding similar results. PI of  casein-opsonized beads 
in parallel  samples averaged less than 25 for all groups. 
vector-transfected K562 cells. Soluble fibronectin inhibited 
the  a5/31 component of phagocytosis in  the  Ctv/33 transfec- 
tants, since addition of P5D2 anti-/31 did not further inhibit 
fibronectin bead phagocytosis in the presence of 300 #g/ml 
fibronectin.  In the presence of Mn  ++,  A1A5,  or 8A2,  cry/33 
ligation inhibited phagocytosis, since 7G2 anti-133 inhibited 
ingestion  in  the  c~d33 transfectants  completely in  each  of 
these cases  (Fig.  8  B).  For 131-activating mAb as  well as 
Mn  ÷÷, H7 overcame the inhibitory effect of 7G2. 
In contrast, adhesion of both control and a~/33-expressing 
K562  to  fibronectin-coated  substrates  was  unaffected  by 
soluble fibronectin or by anti-/33 (not shown).  This was true 
for adhesion in the absence or presence of Mn  +÷, A1A5 and 
KA2, all of which enhanced adhesion of K562 approximately 
threefold when included. 
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In addition to its role as an adhesive ligand in extracellular 
matrix,  fibronectin is  a  major opsonin  in  human serum 
which  functions in  both  host defense and wound repair. 
While this aspect of fibronectin function has been known for 
many years, the molecular aspects of fibronectin's interaction 
with cells as an opsonin, rather than as a conventional adhe- 
sion molecule, are not known. Among the reasons for this 
lack of understanding is the large number of potential fibro- 
nectin receptors on macrophages, the major effector cells in 
recognition of fibronectin-opsonized bacteria and debris. In 
an attempt to develop a molecular understanding of fibro- 
nectin-macrophage interactions in host defense and wound 
repair, we tested the effects of monoclonal antibodies against 
specific fibronectin receptors on macrophage recognition of 
fibronectin-opsonized particles. We found that monoclonal 
antibodies recognizing both Ctv/33 and ct5/31 inhibited the up- 
take of  fibronectin-opsonized  particles significantly, but that, 
surprisingly, their effects were not additive. 
To study the apparent lack of independence of these two 
macrophage integrin fibronectin receptors in more detail, we 
transfected otvB3 into K562  cells,  which  express  O~5/31 as 
their predominant integrin. In these cells ot~/33 ligation in- 
hibited ot5/3~ phagocytic function. This finding explained the 
lack of additive effects  of the  antibodies on macrophage 
phagocytosis of fibronectin beads.  Because these antibod- 
ies did not inhibit fibronectin-mediated phagocytosis com- 
pletely in  macrophages,  the possibility of a  contribution 
from  other  fibronectin  receptors  remains.  However,  our 
transfectant data did not suggest any contribution from otv/35 
or otM/32, and antibodies to ~4B~ did not inhibit macrophage 
fibronectin-mediated phagocytosis  (Blystone,  S.  D.,  and 
E. J.  Brown, unpublished),  suggesting these integrins are 
not involved in  fibronectin-mediated phagocytosis.  Other 
non-integrin receptors may account for the residual binding 
and ingestion (10). 
The most striking observation from the transfectants is 
that c~/33 ligation inhibits a5/31 phagocytic function. This 
effect results not from steric hindrance, as would occur if the 
two receptors were closely associated in the plasma mem- 
brane,  but  from  signal  transduction.  The  effect on  ~5/3~ 
function is quite specific for av/33 ligation, since neither the 
closely related integrin c~/35 nor c~M/32 have the same effect. 
The  failure of ligation of a~/35 to  affect c~5/3L phagocytic 
function suggests that there are  /33-specific sequences  re- 
quired for the signal transduction.  Because both the iso- 
quinolone sulfonamide H7 and calphostin C inhibit signal 
transduction from ot~/33, it is tempting to speculate that a 
protein kinase C is involved in the signaling pathway.  The 
failure of PMA to affect fibronectin bead phagocytosis does 
not invalidate this hypothesis, since PMA is a nonspecific ac- 
tivator of many protein kinase C isoforms and may lead to 
activation  of  signal  transduction  pathways  with  varying 
effects on phagocytosis. The failure of protein tyrosine ki- 
nase inhibitors to affect c~/33 signal transduction suggests 
that the recently elucidated pathway involving pp125 FA~ and 
c-src (18, 38, 56), which is engaged on integrin cross-linking 
or adhesion to ligand-coated substrate, is not involved in the 
regulation of c~5/31 phagocytosis by c~/33. 
Regulation of c~B~ function by ct~/33 ligation is relatively 
subtle,  since  it affects phagocytosis but  not  adhesion by 
cts/31, c~5flt can adopt two conformations, which have two 
distinct affinities for fibronectin (4, 5, 26, 51, 54). Our data 
suggest that fibronectin-mediated phagocytosis requires the 
higher affinity conformation, since addition of Mn  ++ or ac- 
tivating anti-/31 mAb  is  required  in  K562.  The  fact that 
phagocytosis can be inhibited by fibronectin in solution is 
support of this hypothesis. Adhesion to a fibronectin-coated 
surface does not require the high affinity conformation of 
o~5/3t, since it is unaffected by fibronectin in solution, even 
in the presence of Mn  ++ or activating mAb. These data sug- 
gest the hypothesis that av/33 ligation specifically regulates 
c~5/3t functions which require the high affinity state of the 
receptor. Signal transduction from O~v/33 may inhibit induc- 
tion of the high affinity state by Mn  ++ or activating antibod- 
ies,  or may regulate a  subsequent  step  in  attachment of 
fibronectin-opsonized particles for which the high affinity 
receptor is necessary. Because the mAb and Mn  ++ induce 
the high affinity conformation even in detergent-solubilized 
receptors,  we  favor the  hypothesis that the  target of the 
av/33-dependent signal transduction is a process subsequent 
to development of the high affinity state. 
The signal transduction between ot~/33 and ct5/31 is a uni- 
directional process,  since ligation of ot5/3~ does not affect 
the binding and phagocytic properties of otv/33. It is possible 
that  otv/33 is  not a  high  affinity receptor  for  fibronectin, 
since it is not inhibited by fibronectin in solution, and that, 
unlike ot5/3~, the high affinity state of this receptor (if it ex- 
ists) is not required for phagocytosis. 
Little is known about the functions of the high affinity  state 
of o~5/3~ or any integrin. Macrophage phagocytosis of fibro- 
nectin-opsonized targets is one of the first identified cellular 
functions which clearly requires the high affinity integrin 
state.  Platelet ot~/33 binding of fibrinogen requires induc- 
tion of high affinity; this is the best understood integrin 
affinity regulation (36).  Since Ctnb/33 binds fibrinogen on a 
surface without activation (55),  the role of the high affinity 
state is to induce platelet aggregation rather than to mediate 
adhesion to a nascent thrombus. The leukocyte/32 integrins 
bind ligand efficiently only after cell activation (1, 2). In par- 
ticular, otM/32 (Mac-l) function on phagocytes has similari- 
ties to c~5/3t. Like O~sB~, Mac-1 recognizes and leads to in- 
gestion of infectious agents and other opsonized material. 
Mac-1 binds its C3bi ligand efficiently only after cell activa- 
tion (65).  However,  it is unclear that increased/32 integrin 
avidity after activation represents a change in affinity; other 
mechanisms such as receptor clustering (24)  may account 
for increased binding of cells to ligand. To date, changes in 
affinity of the/32 integrins have not been documented. It is 
interesting that c~vB3 ligation has  opposite effects  on c¢5/3~ 
and aM/32 function in leukocytes (62),  perhaps suggesting 
differences in the mechanism of  activation of  these receptors. 
O~v/33 may affect the function of other integrins as well. In 
this light, it is important to reconsider the mechanisms by 
which antibodies to or ligation of ct~B3 regulate cell func- 
tions in vivo and in vitro.  While data showing a  role for 
a~/33 in phenomena as diverse as increase in [Ca++]i in en- 
dothelial cells on adhesion to fibronectin (57) and in mela- 
noma metastasis (27, 49) have been interpreted as resulting 
directly from adhesion of ot~/33 to a  ligand, an alternative 
explanation is that anti-av/33 or even O~v/33 ligand could affect 
the function of OLs#~ or other integrins. 
Finally, what is the physiologic role for conversion of mac- 
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low affinity adhesion receptor by av/33 ligation? Expression 
of o~5/~1 in monocytes has been shown to precede expression 
of av/~3 during  differentiation  into  macrophages.  Perhaps 
expression  of c~v/33 during  differentiation permits  receptor 
specialization: a5/31  assumes primarily an adhesive function 
in the tissue macrophage,  while c~5/31 becomes the primary 
receptor  for recognition  and  phagocytosis  of fibronectin- 
opsonized particles.  A  role for ~,f13 in the recognition of 
fibronectin-opsonized material, rather than adhesion, could 
explain the intralumenal localization of otv/33 on endothelial 
cells (19). 
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